This study will examine the efficacy and safety of Xalacom comparing with those of Xalatan
in Japanese patients with POAG or OH.
Minimum age: 20 Years.
Maximum age: N/A.
Gender(s): Both.
Pfizer Investigational Site, Fujuoka 812-0011, Japan
Pfizer Investigational Site, Fukuoka 814-0133, Japan
Pfizer Investigational Site, Fukuoka 812-0036, Japan
Pfizer Investigational Site, Fukuoka 810-0002, Japan
Pfizer Investigational Site, Gifu 501-1194, Japan
Pfizer Investigational Site, Hiroshima 734-8551, Japan
Pfizer Investigational Site, Niigata 951-8122, Japan
Pfizer Investigational Site, Osaka 537-0025, Japan
Pfizer Investigational Site, Osaka 557-0044, Japan
Pfizer Investigational Site, Osaka, Japan
Pfizer Investigational Site, Shizuoka 420-0833, Japan
Pfizer Investigational Site, Sugita, Japan
Pfizer Investigational Site, Ichinomiya, Aichi 491-0837, Japan
Pfizer Investigational Site, Ichinomiya, Aichi 491-0858, Japan
Pfizer Investigational Site, Nagoya, Aichi 460-0011, Japan
Pfizer Investigational Site, Nagoya, Aichi 466-0054, Japan
Pfizer Investigational Site, Nagoya, Aichi 467-0806, Japan
Pfizer Investigational Site, Narashino, Chiba 275-0016, Japan
Pfizer Investigational Site, Sapporo, Hokkaido 001-0016, Japan
Pfizer Investigational Site, Sapporo, Hokkaido 001-0039, Japan
Pfizer Investigational Site, Sapporo, Hokkaido 004-0041, Japan
Pfizer Investigational Site, Sapporo, Hokkaido 062-0020, Japan
Pfizer Investigational Site, Koube, Hyogo 650-0017, Japan
Pfizer Investigational Site, Kanazawa, Ishikawa 920-0934, Japan
Pfizer Investigational Site, Fujisawa, Kanagawa 251-0052, Japan
Pfizer Investigational Site, Kamakura, Kanagawa 248-0035, Japan
Pfizer Investigational Site, Sagamihara, Kanagawa 228-0806, Japan
Pfizer Investigational Site, Yokohama, Kanagawa 222-0011, Japan
Pfizer Investigational Site, Sapporo, Kokkaido 003-0062, Japan
Pfizer Investigational Site, Uji, Kyoto 611-0043, Japan
Pfizer Investigational Site, Miyakonojo, Miyazaki 885-0051, Japan
Pfizer Investigational Site, Kumagaya, Saitama 360-0843, Japan
Pfizer Investigational Site, Tokorozawa, Saitama 359-1116, Japan
Pfizer Investigational Site, Fuji, Shizuoka 416-0952, Japan
Pfizer Investigational Site, Fuji, Shizuoka 419-0204, Japan
Pfizer Investigational Site, Mishima, Shizuoka 411-0824, Japan
Pfizer Investigational Site, Susono, Shizuoka 410-1102, Japan
Pfizer Investigational Site, Bunkyo-ku, Tokyo 113-8655, Japan
Pfizer Investigational Site, Chiyoda-ku, Tokyo 101-0062, Japan
Pfizer Investigational Site, Chiyoda, Tokyo 102-8161, Japan
Pfizer Investigational Site, Hachioji, Tokyo 192-0046, Japan
Pfizer Investigational Site, Hamura, Tokyo 205-0001, Japan
Pfizer Investigational Site, Katsushika-ku, Tokyo 125-0041, Japan
Pfizer Investigational Site, Kiyose, Tokyo 204-0021, Japan
Pfizer Investigational Site, Koto-ku, Tokyo 136-0076, Japan
Pfizer Investigational Site, Meguro-ku, Tokyo 153-0043, Japan
Pfizer Investigational Site, Meguro, Tokyo 152-0032, Japan
Pfizer Investigational Site, Musashino, Tokyo 180-0022, Japan
Pfizer Investigational Site, Musashino, Tokyo 180-0004, Japan
Pfizer Investigational Site, Ota-ku, Tokyo 144-052, Japan
Pfizer Investigational Site, Setagaya, Tokyo 157-0066, Japan
Pfizer Investigational Site, Shinjuku, Tokyo 160-0004, Japan
Pfizer Investigational Site, Tachikawa, Tokyo 190-0003, Japan
Pfizer Investigational Site, Taito-ku, Tokyo 110-015, Japan